All news from Endocrinology
Diabetes can lead to ulcers that patients do not even feel or notice until the sight of blood. And because ulcers can not heal on their own, 14 to 24% of diabetics in the U.S. who experience them end up losing their toes, foot or leg.
The study used genetic data of more than 880,000 participants. A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease.
For patients who take medication to treat hypothyroidism, being treated with too much medication can lead to an increased risk of atrial fibrillation, a common heart rhythm disorder associated with stroke, a new study of more than 174,000 patients has found.
Cancer cells are often described as cells "gone bad" or "renegade." New research reveals that in some of the deadliest cases of pancreatic cancer, these rebellious cells have an unexpected addiction. Now, scientists are investigating if that addiction can be used to bring about a tumor's end.
The evaluation of thyroid nodules by fine-needle aspiration has been the standard for almost 30 years, despite significant shortcomings in sensitivity and specificity. Recent data from our laboratory have suggested that molecular profiling permits the discrimination of specific types of thyroid nodules.
People with type 1 diabetes who use marijuana may double their risk of developing a life-threatening complication, a new study suggests. Diabetic ketoacidosis (DKA) occurs when there is not enough insulin to break down sugar in the body, so the body burns fat for fuel instead.
New research has linked adolescent obesity with up to a four-fold increased risk of pancreatic cancer later in life. The study's results also suggest that overweight and even higher weight within the "normal" weight range in men may increase pancreatic cancer risk in a graded manner.
Diabetes mellitus is a chronic noncommunicable disease characterized by hyperglycemia and is associated with chronic disorders affecting the overall quality of life. As of 2017, the prevalence of diabetes in Lebanon is estimated to be 14.6%.
Depression is noted to be common among Lebanese citizens, present in around 17.3%. This study aims to investigate the prevalence of depression among diabetics and their relationship with poor glycemic control and diabetes.
An international collaboration co-led by researchers at the Walter and Eliza Hall Institute has made a discovery that could make therapeutic insulins more effective by better mimicking the way insulin works in the body. The findings could improve treatments for diabetes, to that disease of the lives of millions of people worldwide.
The study was published in Nature Communications. The study reveals the first definitive 3-D image of how insulin successfully interacts with its receptor to 'gatekeeper' for transmitting information into cells in a process that is crucial for instructing cells to lower blood sugar levels in the body.
Understanding exactly what this process looks like could inform the design of faster-acting and longer-lasting insulin therapies.
People with type 1 diabetes may be more likely to develop potentially fatal complications when they use cannabis, a recent study suggests. Researchers surveyed 450 patients with type 1 diabetes in Colorado, where cannabis is legal for medical and recreational use.
Overall, 30% of the participants used cannabis. The study was published in JAMA Internal Medicine.
Researchers have discovered how the frontline Type 2 diabetes drug metformin may work to help cells better take up and use glucose. They may also explain other potentially beneficial effects of metformin the for prevention of a variety of chronic diseases, including cancers. The study was published today in the prestigious journal Cell.
A new study examined the relationship between fasting hyperglucagonemia-which can negatively affect glucose metabolism in patients with type 2 diabetes (T2D) -and several biochemical and glycemic factors in subjects with T2D or in a nondiabetic control group. The study results, which help to elucidate the mechanisms that underlie fasting hyperglucagonemia, are published in Metabolic Syndrome and Related Disorders.